mhurhangee/patent-ind-claim-en huggingface dataset:
A high efficiency hydrogen fueled thermodynamic fuel cell system for a high altitude aircraft, said system comprising: an air inlet ; a fan downstream from air inlet ; a first air compressor fluidically coupled to said air inlet downstream from said fan , said first compressor adapted to compress inletted air into a fuel cell air pathway; a second air compressor fluidically coupled to said first air compressor downstream from said first air compressor ; a third air compressor fluidically coupled to said second air compressor downstream from said second air compressor ; a liquid hydrogen reservoir ; a liquid hydrogen pump coupled to said liquid hydrogen reservoir , said pump adapted to pressurize liquid hydrogen through a hydrogen pathway; a first heat exchanger adapted to cool air downstream of said first air compressor with inletted air downstream from said fan ; a second heat exchanger adapted to cool air downstream of said first compressor with hydrogen from said pump ; a third heat exchanger adapted to cool air downstream of said second air compressor with inletted air downstream from said fan ; a fourth heat exchanger adapted to cool air downstream of said second compressor with hydrogen from said pump downstream along said hydrogen pathway from said second heat exchanger ; a hydrogen expander along said hydrogen pathway downstream from said fourth heat exchanger , and a fuel cell , said fuel cell fluidically coupled to said hydrogen pathway downstream of said hydrogen expander , said fuel cell fluidically coupled to said fuel cell air pathway downstream of said third compressor . an air inlet ; a fan downstream from air inlet ; a first air compressor fluidically coupled to said air inlet downstream from said fan , said first compressor adapted to compress inletted air into a fuel cell air pathway; a second air compressor fluidically coupled to said first air compressor downstream from said first air compressor ; a third air compressor fluidically coupled to said second air compressor downstream from said second air compressor ; a liquid hydrogen reservoir ; a liquid hydrogen pump coupled to said liquid hydrogen reservoir , said pump adapted to pressurize liquid hydrogen through a hydrogen pathway; a first heat exchanger adapted to cool air downstream of said first air compressor with inletted air downstream from said fan ; a second heat exchanger adapted to cool air downstream of said first compressor with hydrogen from said pump ; a third heat exchanger adapted to cool air downstream of said second air compressor with inletted air downstream from said fan ; a fourth heat exchanger adapted to cool air downstream of said second compressor with hydrogen from said pump downstream along said hydrogen pathway from said second heat exchanger ; a hydrogen expander along said hydrogen pathway downstream from said fourth heat exchanger , and a fuel cell , said fuel cell fluidically coupled to said hydrogen pathway downstream of said hydrogen expander , said fuel cell fluidically coupled to said fuel cell air pathway downstream of said third compressor .
Arrangement of a pair of coils (A, B) in a local measurement area (M), with a measuring oscillator and an eddy-current damping element at a nominal distance from the pair of coils, a) wherein the coils, as rectangular coils (A, B), overlap within the measurement area (M) in the measuring direction, wherein the overlapping area forms the measurement area (M), b) wherein the coils (A, B) have an overhang of the coil length (L), at in each case one end of the measurement area (M), c) wherein the eddy-current damping element is displaceable with two edges defined transversely to the measuring direction in relation to the pair of coils (A, B) in the measuring direction, and the eddy current damping element at least partially covers both coils of the pair of coils (A, B), wherein only one edge of the eddy current damping element is ever involved in the partial coverage, d) and the coils (A, B) with a measuring oscillator have in each case a linear characteristic of the oscillator frequency (f) as a function of the location (s, Φ) of the eddy current damping element, and e) these linear characteristics have in each case within the family of characteristics a virtual, i.e. outside the measurement area (M), point of rotation (A0, B0) that is largely independent of interferences, i.e. variations of the nominal distance, of tiltings of the eddy-current damping element in the measuring direction and of temperature changes. a) wherein the coils, as rectangular coils (A, B), overlap within the measurement area (M) in the measuring direction, wherein the overlapping area forms the measurement area (M), b) wherein the coils (A, B) have an overhang of the coil length (L), at in each case one end of the measurement area (M), c) wherein the eddy-current damping element is displaceable with two edges defined transversely to the measuring direction in relation to the pair of coils (A, B) in the measuring direction, and the eddy current damping element at least partially covers both coils of the pair of coils (A, B), wherein only one edge of the eddy current damping element is ever involved in the partial coverage, d) and the coils (A, B) with a measuring oscillator have in each case a linear characteristic of the oscillator frequency (f) as a function of the location (s, Φ) of the eddy current damping element, and e) these linear characteristics have in each case within the family of characteristics a virtual, i.e. outside the measurement area (M), point of rotation (A0, B0) that is largely independent of interferences, i.e. variations of the nominal distance, of tiltings of the eddy-current damping element in the measuring direction and of temperature changes.
A method of prognosing prostate cancer, lung cancer, bladder cancer or brain cancer, comprising: (a) determining in a fresh frozen tumor sample from a patient diagnosed of prostate cancer, lung cancer, bladder cancer or brain cancer, the expression of a panel of genes in said tumor sample wherein: (i) for prostate cancer the panel includes at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the panel includes all the cell-cycle genes from Panel C or F; (b) providing a test value by weighting the determined expression of each of a plurality of test genes selected from said panel of genes with a predefined coefficient, and combining the weighted expressions to provide said test value, wherein: (i) for prostate cancer the plurality of test genes includes the at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the plurality of test genes includes all the cell-cycle genes from Panel C or F; and (c) comparing said test value to a reference value, and correlating to an increased likelihood of poor prognosis if said test value is greater than said reference value. (a) determining in a fresh frozen tumor sample from a patient diagnosed of prostate cancer, lung cancer, bladder cancer or brain cancer, the expression of a panel of genes in said tumor sample wherein: (i) for prostate cancer the panel includes at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the panel includes all the cell-cycle genes from Panel C or F; (i) for prostate cancer the panel includes at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the panel includes all the cell-cycle genes from Panel C or F; (b) providing a test value by weighting the determined expression of each of a plurality of test genes selected from said panel of genes with a predefined coefficient, and combining the weighted expressions to provide said test value, wherein: (i) for prostate cancer the plurality of test genes includes the at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the plurality of test genes includes all the cell-cycle genes from Panel C or F; and (i) for prostate cancer the plurality of test genes includes the at least 4 cell-cycle genes selected from Panel C or F, and (ii) for lung cancer, bladder cancer and brain cancer the plurality of test genes includes all the cell-cycle genes from Panel C or F; and (c) comparing said test value to a reference value, and correlating to an increased likelihood of poor prognosis if said test value is greater than said reference value.
A method to produce a sheet of a material containing alkaloids , the method comprising: - mixing particles of the material containing alkaloids , a binder, an aerosol former and water to form a slurry; - casting the slurry to form a cast sheet ; - drying the cast sheet by means of a heated fluid; - recovering heat from exhausts produced during drying ; - recovering volatile substances from exhausts produced during drying ; - obtaining a flavor extract from the recovered volatile substances; - transporting the cast sheet along a transport direction during the drying ; - collecting exhausts produced in the drying step from different locations along the transport direction; and - obtaining a different substance from the exhaust depending on the location of collection. - mixing particles of the material containing alkaloids , a binder, an aerosol former and water to form a slurry; - casting the slurry to form a cast sheet ; - drying the cast sheet by means of a heated fluid; - recovering heat from exhausts produced during drying ; - recovering volatile substances from exhausts produced during drying ; - obtaining a flavor extract from the recovered volatile substances; - transporting the cast sheet along a transport direction during the drying ; - collecting exhausts produced in the drying step from different locations along the transport direction; and - obtaining a different substance from the exhaust depending on the location of collection.
A polycarbonate composite material, characterized in that , it comprises the following components: 30-80 parts by weight of a polycarbonate; 5-40 parts by weight of an ABS; 5-80 parts by weight of a filler; wherein, based on a total weight of the polycarbonate composite material, a weight content of iron element is 5 ppm-40 ppm, and a weight content of copper element is 0.1 ppm-10 ppm; the polycarbonate has a PDI coefficient ranging from 2.0 to 4.0; a melt flow rate of the polycarbonate measured according to ASTM D1238 at 300°C under a load of 1.2 kg is 3g/10min-30g/10min; the ABS copolymer has an average particle size ranging from 500 nm to 2000 nm; a glass transition temperature of the ABS copolymer is greater than 25°C; and the filler is a mineral filler. 30-80 parts by weight of a polycarbonate; 5-40 parts by weight of an ABS; 5-80 parts by weight of a filler; wherein, based on a total weight of the polycarbonate composite material, a weight content of iron element is 5 ppm-40 ppm, and a weight content of copper element is 0.1 ppm-10 ppm; the polycarbonate has a PDI coefficient ranging from 2.0 to 4.0; a melt flow rate of the polycarbonate measured according to ASTM D1238 at 300°C under a load of 1.2 kg is 3g/10min-30g/10min; the ABS copolymer has an average particle size ranging from 500 nm to 2000 nm; a glass transition temperature of the ABS copolymer is greater than 25°C; and the filler is a mineral filler.
A high pressure freezing cartridge for use in vitrification of a biological sample , the cartridge being adapted to fixedly hold a sample chamber at a sample chamber position inside the cartridge , a refrigerant channel arrangement comprising at least one refrigerant channel being provided in the cartridge and extending from a surface of the cartridge to the sample chamber position, and the cartridge comprising a baffle structure at a baffle position being adapted to interact with a refrigerant stream in the refrigerant channel arrangement before the refrigerant of the refrigerant stream reaches the sample chamber position in the cartridge , wherein the cartridge is formed using cartridge elements being brought into an operational configuration, the cartridge elements including two holding elements and a middle plate , the middle plate being adapted to be sandwiched between the holding elements in the operational configuration of the cartridge elements ; wherein the middle plate is a flat element comprising an opening adapted to form the sample chamber by fitting enclosing elements into the opening ; and characterized in that the baffle structure is configured as a flat disc with an engaging element , the baffle structure being positioned or fixedly held by at least one of the cartridge elements at the baffle position by engaging the engaging element to the respective cartridge element . wherein the cartridge is formed using cartridge elements being brought into an operational configuration, the cartridge elements including two holding elements and a middle plate , the middle plate being adapted to be sandwiched between the holding elements in the operational configuration of the cartridge elements ; wherein the middle plate is a flat element comprising an opening adapted to form the sample chamber by fitting enclosing elements into the opening ; and characterized in that the baffle structure is configured as a flat disc with an engaging element , the baffle structure being positioned or fixedly held by at least one of the cartridge elements at the baffle position by engaging the engaging element to the respective cartridge element .
A method of making an article, comprising: depositing a plurality of layers to form a three-dimensional preform, wherein the plurality of layers is formed from a beryllium-containing composition comprising beryllium powder and a binder, and wherein after each layer is deposited, the layer is then partially curing by exposure to a heat source; sintering the three-dimensional preform to form a sintered preform wherein the binder is burned-off during the sintering; and infiltrating the sintered preform with at least one infiltrating metal to form the article; wherein the beryllium powder is composed of pure beryllium or a beryllium alloy containing from 35 wt% to 65 wt% beryllium and from 35 wt% to 65 wt% aluminum. depositing a plurality of layers to form a three-dimensional preform, wherein the plurality of layers is formed from a beryllium-containing composition comprising beryllium powder and a binder, and wherein after each layer is deposited, the layer is then partially curing by exposure to a heat source; sintering the three-dimensional preform to form a sintered preform wherein the binder is burned-off during the sintering; and infiltrating the sintered preform with at least one infiltrating metal to form the article; wherein the beryllium powder is composed of pure beryllium or a beryllium alloy containing from 35 wt% to 65 wt% beryllium and from 35 wt% to 65 wt% aluminum.
A method of determining if a patient suffering from an allergy is responsive to therapy with one or more antibodies or antigen binding fragments thereof specific for the allergen, the method comprising: (i) extracting allergen specific IgE from any one or more of a sample of tissue or an extract thereof, or a biological fluid, or a blood sample from a patient suffering from an allergy; (ii) mixing the allergen specific IgE from the patient sample with the allergen and with one or more antibodies or antigen binding fragments thereof specific for the allergen; and (iii) determining if the addition of the antibodies or antigen binding fragments thereof specific for the allergen blocks the binding of the allergen specific IgE from step i) to the allergen using an in vivo allergen-specific non-human animal model of passive cutaneous anaphylaxis (PCA), wherein the ability of the one or more antibodies or antigen binding fragments thereof specific for the allergen to block the binding of allergen specific IgE from step i) to the allergen is indicative that the patient suffering from an allergy is responsive to therapy with the one or more antibodies specific for the allergy, wherein the allergen is the cat allergen Fel d1, and wherein the one or more antibodies or antigen binding fragments specific for the allergen are human monoclonal antibodies that bind specifically to Fel d1, and wherein the one or more antibodies comprise the heavy chain complementarity determining regions (HCDRs) of a heavy chain variable region (HCVR) comprising the amino acid sequence of SEQ ID NO: 2 or 18 and the light chain complementarity determining regions (LCDRs) of a light chain variable region (LCVR) comprising the amino acid sequence of SEQ ID NO: 10 or 26. (i) extracting allergen specific IgE from any one or more of a sample of tissue or an extract thereof, or a biological fluid, or a blood sample from a patient suffering from an allergy; (ii) mixing the allergen specific IgE from the patient sample with the allergen and with one or more antibodies or antigen binding fragments thereof specific for the allergen; and (iii) determining if the addition of the antibodies or antigen binding fragments thereof specific for the allergen blocks the binding of the allergen specific IgE from step i) to the allergen using an in vivo allergen-specific non-human animal model of passive cutaneous anaphylaxis (PCA),
A method of establishing position dependent focal laws for the ultrasonic inspection of a specimen with complex geometry using a phased array scanner, said method being performed by a dedicated module located on a computing device and comprising the steps of: (a) the dedicated module loading a computer model of said specimen into a portion of memory; (b) the dedicated module partitioning said model into distinct regions; (c) the dedicated module generating a distinct set of focal laws for each of said distinct regions; and (d) the dedicated module associating each position of the scanner with at least one of said distinct regions and storing the association in memory; whereby during ultrasonic inspection of said specimen, each position of said scanner utilizes said distinct set of focal laws associated with said at least one region, wherein partitioning said model into distinct regions comprises: (i) characterizing a surface corresponding to a first scanner position on said model, and designating this surface as belonging to a first region; (ii) characterizing each of the surfaces corresponding to all other scanner positions on said model; (iii) using a defined measure of difference between surface characteristics to calculate a set of error values, each error value representing a difference in surface characteristics between one of the surfaces in said all other scanner positions and the surface in said first scanner position; (iv) selecting a second scanner position from said all other scanner positions, said second scanner position being the scanner position having the largest error value; and (v) designating the surface corresponding to the second scanner position as belonging to said second region. (a) the dedicated module loading a computer model of said specimen into a portion of memory; (b) the dedicated module partitioning said model into distinct regions; (c) the dedicated module generating a distinct set of focal laws for each of said distinct regions; and (d) the dedicated module associating each position of the scanner with at least one of said distinct regions and storing the association in memory; (i) characterizing a surface corresponding to a first scanner position on said model, and designating this surface as belonging to a first region; (ii) characterizing each of the surfaces corresponding to all other scanner positions on said model; (iii) using a defined measure of difference between surface characteristics to calculate a set of error values, each error value representing a difference in surface characteristics between one of the surfaces in said all other scanner positions and the surface in said first scanner position; (iv) selecting a second scanner position from said all other scanner positions, said second scanner position being the scanner position having the largest error value; and (v) designating the surface corresponding to the second scanner position as belonging to said second region.
A robot arm comprising a first arm segment having a first longitudinal axis and a second arm segment having a second longitudinal axis , the first and second arm segments being coupled to each other by a first revolute joint having a first rotation axis which is perpendicular to the first longitudinal axis and a second revolute joint having a second rotation axis which intersects and is non-parallel to the first rotation axis, and a joint mechanism for articulating the first arm segment relative to the second arm segment about the first and second rotation axes, the joint mechanism comprising: a first driven gear disposed about an axle coincident with the first rotation axis, the axle being fast with the first arm segment of the robot arm; a second driven gear disposed about the second rotation axis and fast with the second arm segment of the robot arm and fast with the first driven gear about the first rotation axis; a first drive gear configured to drive the first driven gear to rotate about the axle, the first drive gear being arranged to engage the first driven gear; a second drive gear for driving the second driven gear to rotate about the second rotation axis; an intermediary gear arrangement arranged to engage the second drive gear and the second driven gear and being disposed about the first rotation axis, whereby rotation of the intermediary gear arrangement relative to the first arm segment about the first rotation axis can be driven, the intermediary gear arrangement comprising a first intermediate gear arranged to engage the second drive gear, and a second intermediate gear arranged to engage the second driven gear; and characterised in that : the robot arm is a surgical robot arm; the second rotation axis is perpendicular to the second longitudinal axis; and at least one of the first driven gear and the first intermediate gear is a sector. a first driven gear disposed about an axle coincident with the first rotation axis, the axle being fast with the first arm segment of the robot arm; a second driven gear disposed about the second rotation axis and fast with the second arm segment of the robot arm and fast with the first driven gear about the first rotation axis; a first drive gear configured to drive the first driven gear to rotate about the axle, the first drive gear being arranged to engage the first driven gear; a second drive gear for driving the second driven gear to rotate about the second rotation axis; an intermediary gear arrangement arranged to engage the second drive gear and the second driven gear and being disposed about the first rotation axis, whereby rotation of the intermediary gear arrangement relative to the first arm segment about the first rotation axis can be driven, the intermediary gear arrangement comprising a first intermediate gear arranged to engage the second drive gear, and a second intermediate gear arranged to engage the second driven gear; and the robot arm is a surgical robot arm; the second rotation axis is perpendicular to the second longitudinal axis; and at least one of the first driven gear and the first intermediate gear is a sector.